To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
We are pleased to present an XYLT2 knockout HEK293T cell line, designed to facilitate research on glycosaminoglycan biosynthesis. This cell line, lacking the XYLT2-encoded xylosyltransferase 2, offers a valuable tool for researchers to investigate the specific roles of XYLT2 in glycosaminoglycan biosynthesis and its impact on cellular functions. Utilizing HEK293T cells, a platform well-suited for gene function and regulation studies, researchers can gain a deeper understanding of the role of XYLT2 in maintaining protein homeostasis.
Product Type
KO Cell Lines
Species
Human
Cell Morphology
Epithelial-like, adherent
Passage Ratio
1:2~1:4
Cell Line
HEK293T
Lineage
Embryonic kidney
Specification
Cell Viability
>90%
Sterility Test
The sterility test indicated an absence of microbial growth.
Identity Test
STR identification
Mycoplasma Test
Negative
Virus Test
Negative for HIV, HBV and HCV.
Genetic Stability Testing
We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements.
Validation
PCR, Sanger Sequencing
Culture Medium
DMEM & FBS & Penicillin/Streptomycin
Application
Functional assay
Size
1 M cells/vial*2
Product Format
Frozen
Shipping
Dry ice
Availability Status
Made to order
Handling Notes
Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to.
Product Disclaimer
This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous.
Xylosyltransferase that initiates glycosaminoglycan chain biosynthesis; enzyme activity is increased in scleroderma patients and serves as a diagnostic marker.